Table of Content

1 Age Related Macular Degeneration Drug Market Introduction and Overview
1.1 Age Related Macular Degeneration Drug Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Age Related Macular Degeneration Drug Revenue and Market Share by Manufacturer
2.2 Manufacturers Age Related Macular Degeneration Drug Production Sites, Area Served, Product Types
2.3 Age Related Macular Degeneration Drug Market Competitive Situation and Trends
2.3.1 Age Related Macular Degeneration Drug Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Applied Genetic Technologies Corp
3.1.1 Applied Genetic Technologies Corp Company Profile
3.1.2 Age Related Macular Degeneration Drug Product Overview
3.1.3 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Market Performance (2019-2024)
3.1.4 Applied Genetic Technologies Corp Business Overview
3.2 Astellas Pharma Inc
3.2.1 Astellas Pharma Inc Company Profile
3.2.2 Age Related Macular Degeneration Drug Product Overview
3.2.3 Astellas Pharma Inc Age Related Macular Degeneration Drug Market Performance (2019-2024)
3.2.4 Astellas Pharma Inc Business Overview
3.3 Benitec Biopharma Ltd
3.3.1 Benitec Biopharma Ltd Company Profile
3.3.2 Age Related Macular Degeneration Drug Product Overview
3.3.3 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Market Performance (2019-2024)
3.3.4 Benitec Biopharma Ltd Business Overview
3.4 Biokine Therapeutics Ltd
3.4.1 Biokine Therapeutics Ltd Company Profile
3.4.2 Age Related Macular Degeneration Drug Product Overview
3.4.3 Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Market Performance (2019-2024)
3.4.4 Biokine Therapeutics Ltd Business Overview
3.5 Crinetics Pharmaceuticals Inc
3.5.1 Crinetics Pharmaceuticals Inc Company Profile
3.5.2 Age Related Macular Degeneration Drug Product Overview
3.5.3 Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Market Performance (2019-2024)
3.5.4 Crinetics Pharmaceuticals Inc Business Overview
3.6 Critical Pharmaceuticals Ltd
3.6.1 Critical Pharmaceuticals Ltd Company Profile
3.6.2 Age Related Macular Degeneration Drug Product Overview
3.6.3 Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Market Performance (2019-2024)
3.6.4 Critical Pharmaceuticals Ltd Business Overview
3.7 Daiichi Sankyo Company Ltd
3.7.1 Daiichi Sankyo Company Ltd Company Profile
3.7.2 Age Related Macular Degeneration Drug Product Overview
3.7.3 Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Market Performance (2019-2024)
3.7.4 Daiichi Sankyo Company Ltd Business Overview
3.8 Diffusion Pharmaceuticals Inc
3.8.1 Diffusion Pharmaceuticals Inc Company Profile
3.8.2 Age Related Macular Degeneration Drug Product Overview
3.8.3 Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Market Performance (2019-2024)
3.8.4 Diffusion Pharmaceuticals Inc Business Overview
3.9 Dong-A Socio Holdings Co Ltd
3.9.1 Dong-A Socio Holdings Co Ltd Company Profile
3.9.2 Age Related Macular Degeneration Drug Product Overview
3.9.3 Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Market Performance (2019-2024)
3.9.4 Dong-A Socio Holdings Co Ltd Business Overview
3.10 Eleven Biotherapeutics Inc
3.10.1 Eleven Biotherapeutics Inc Company Profile
3.10.2 Age Related Macular Degeneration Drug Product Overview
3.10.3 Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Market Performance (2019-2024)
3.10.4 Eleven Biotherapeutics Inc Business Overview
3.11 Elsalys Biotech SAS
3.11.1 Elsalys Biotech SAS Company Profile
3.11.2 Age Related Macular Degeneration Drug Product Overview
3.11.3 Elsalys Biotech SAS Age Related Macular Degeneration Drug Market Performance (2019-2024)
3.11.4 Elsalys Biotech SAS Business Overview
3.12 Lupin Ltd
3.12.1 Lupin Ltd Company Profile
3.12.2 Age Related Macular Degeneration Drug Product Overview
3.12.3 Lupin Ltd Age Related Macular Degeneration Drug Market Performance (2019-2024)
3.12.4 Lupin Ltd Business Overview
4 Global Age Related Macular Degeneration Drug Historical and Forecast Market Analysis by Type
4.1 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type
4.2 Global Age Related Macular Degeneration Drug Revenue Market Forecast by Type (2024-2030)
5 Global Age Related Macular Degeneration Drug Historical and Forecast Market Analysis by Application
5.1 Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2019-2024)
5.2 Age Related Macular Degeneration Drug Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Age Related Macular Degeneration Drug Market Size & Forecast (2019-2030)
6.2 Age Related Macular Degeneration Drug Growth Trends Analysis by Regions
6.2.1 Age Related Macular Degeneration Drug Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Age Related Macular Degeneration Drug Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Age Related Macular Degeneration Drug Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Age Related Macular Degeneration Drug Market Size & Forecast (2019-2030)
6.2.5 Europe Age Related Macular Degeneration Drug Market Size & Forecast (2019-2030)
6.2.6 China Age Related Macular Degeneration Drug Market Size & Forecast (2019-2030)
6.2.7 Japan Age Related Macular Degeneration Drug Market Size & Forecast (2019-2030)
6.2.8 Korea Age Related Macular Degeneration Drug Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Age Related Macular Degeneration Drug Market Size & Forecast (2019-2030)
6.2.10 India Age Related Macular Degeneration Drug Market Size & Forecast (2019-2030)
6.2.11 South America Age Related Macular Degeneration Drug Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Age Related Macular Degeneration Drug Market Size & Forecast (2019-2030)
7 North America
7.1 North America Age Related Macular Degeneration Drug Revenue by Players
7.2 North America Age Related Macular Degeneration Drug Revenue by Types
7.3 North America Age Related Macular Degeneration Drug Revenue by Applications
7.4 North America Age Related Macular Degeneration Drug Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Age Related Macular Degeneration Drug Revenue by Players
8.2 Europe Age Related Macular Degeneration Drug Revenue by Types
8.3 Europe Age Related Macular Degeneration Drug Revenue by Applications
8.4 Europe Age Related Macular Degeneration Drug Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Age Related Macular Degeneration Drug Revenue by Players
9.2 China Age Related Macular Degeneration Drug Revenue by Types
9.3 China Age Related Macular Degeneration Drug Revenue by Applications
9.4 China Age Related Macular Degeneration Drug Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Age Related Macular Degeneration Drug Revenue by Players
10.2 Japan Age Related Macular Degeneration Drug Revenue by Types
10.3 Japan Age Related Macular Degeneration Drug Revenue by Applications
10.4 Japan Age Related Macular Degeneration Drug Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Age Related Macular Degeneration Drug Revenue by Players
11.2 Korea Age Related Macular Degeneration Drug Revenue by Types
11.3 Korea Age Related Macular Degeneration Drug Revenue by Applications
11.4 Korea Age Related Macular Degeneration Drug Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Age Related Macular Degeneration Drug Revenue by Players
12.2 Southeast Asia Age Related Macular Degeneration Drug Revenue by Types
12.3 Southeast Asia Age Related Macular Degeneration Drug Revenue by Applications
12.4 Southeast Asia Age Related Macular Degeneration Drug Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Age Related Macular Degeneration Drug Revenue by Players
13.2 India Age Related Macular Degeneration Drug Revenue by Types
13.3 India Age Related Macular Degeneration Drug Revenue by Applications
13.4 India Age Related Macular Degeneration Drug Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Age Related Macular Degeneration Drug Revenue by Players
14.2 South America Age Related Macular Degeneration Drug Revenue by Types
14.3 South America Age Related Macular Degeneration Drug Revenue by Applications
14.4 South America Age Related Macular Degeneration Drug Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Age Related Macular Degeneration Drug Revenue by Players
15.2 Middle East & Africa Age Related Macular Degeneration Drug Revenue by Types
15.3 Middle East & Africa Age Related Macular Degeneration Drug Revenue by Applications
15.4 Middle East & Africa Age Related Macular Degeneration Drug Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Age Related Macular Degeneration Drug Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Age Related Macular Degeneration Drug Industrial Chain Analysis
17 Age Related Macular Degeneration Drug Industry Dynamic Analysis
17.1 Age Related Macular Degeneration Drug Market Trends Analysis
17.2 Age Related Macular Degeneration Drug Market Drivers Analysis
17.3 Age Related Macular Degeneration Drug Market Challenges Analysis
17.4 Age Related Macular Degeneration Drug Market Restraints Analysis
18 Research Findings and Conclusion